As of November 2024, Northwest Biotherapeutics has a market cap of $357.69M. This makes Northwest Biotherapeutics the world's 13563th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $648.97M | -19.65% |
2023 | $807.69M | -10.26% |
2022 | $900.00M | 11.43% |
2021 | $807.69M | -54.25% |
2020 | $1.77B | 628.57% |
2019 | $242.31M | 0.00% |
2018 | $242.31M | -12.50% |
2017 | $276.92M | -31.43% |
2016 | $403.85M | -89.06% |
2015 | $3.69B | -40.19% |
2014 | $6.17B | 41.91% |
2013 | $4.35B | 20.83% |
2012 | $3.60B | -45.83% |
2011 | $6.65B | -53.85% |
2010 | $14.40B | -1.27% |
2009 | $14.58B | 146.88% |
2008 | $5.91B | -87.40% |
2007 | $46.89B | 141.90% |
2006 | $19.38B | -30.00% |
2005 | $27.69B | 150.00% |
2004 | $11.08B | -81.82% |
2003 | $60.92B | 37.50% |
2002 | $44.31B | -96.80% |
2001 | $1.38T | - |